Oracle to speed clinical trial submissions with new IRB feature

Oracle Health Sciences has integrated its goBalto Activate cloud service with Quorum Review IRB to streamline the process for researchers to submit clinical trial proposals.

The goBalto Active platform helps healthcare customers with clinical trial planning, data collection and trial execution. Now, with Quorum Review IRB, customers will be able to integrate institutional review board submissions into goBalto Active workflows rather than submitting documents manually.

Principal investigators spend nearly half of their time dealing with administrative burdens such as delays in IRB approvals, according to research cited by Oracle. The company's goal is to streamline clinical research development to get new therapies on the market quicker.

"Quorum joins other leading organizations that are committed to modernizing and rethinking how clinical trials are initiated," said Steve Rosenberg, general manager of Oracle Health Sciences.

"Automation has become critical for reducing the costs and complexities of clinical trials and this new level of integration eliminates time-consuming processes and improves operational efficiencies by addressing an entrenched bottleneck in the initiation process."

More articles on health IT:
NIH should strengthen information-security controls, OIG finds
Google, Mitre Corp. to bring 'synthetic' patient data to developers
CHIME to Senate: There's 'no question' 5G will improve healthcare access, efficiency

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers